Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Rheumatology · Adult-onset Still's Disease

The Biology of AOSD: Why it Mimics Other Diseases

At a Glance

Adult-onset Still's Disease (AOSD) is a disorder of the innate immune system that causes severe inflammation. Because there is no single test to confirm it, doctors must diagnose AOSD by carefully ruling out mimicking conditions like serious infections, lymphoma, and other autoimmune diseases.

Understanding the “why” behind an Adult-onset Still’s Disease (AOSD) diagnosis requires looking deep into your immune system. Unlike more common autoimmune diseases (like lupus or rheumatoid arthritis), which involve the “adaptive” immune system making specific antibodies, AOSD is a disorder of the innate immune system [1][2].

The Biology: An Alarm Stuck on ‘ON’

Your innate immune system is your body’s rapid-response team, built to act quickly against threats. Think of it as a building’s fire alarm system. In AOSD, a specific internal sensor called the NLRP3 inflammasome becomes hyperactive [3][4]. The fire alarm gets stuck in the ‘ON’ position, even though there is no actual external threat.

Once triggered, it floods your body with “bad actor” proteins called cytokines [4][5]:

  • Interleukin-1 (IL-1) and Interleukin-6 (IL-6): These are the primary drivers of the “fire.” They cause the high fevers, joint pain, and full-body inflammation [6][2].
  • Interleukin-18 (IL-18): This cytokine is often extremely high in AOSD and is a key marker that doctors use to monitor disease activity and the risk of complications [4][7].

When these cytokines are released in massive amounts all at once, it is sometimes called a cytokine storm, which leads to the intense physical symptoms you experience [6][8].

The ‘Diagnosis of Exclusion’

AOSD is fundamentally a diagnosis of exclusion [9]. This means there is no single blood test that says “Yes, you have Still’s Disease.” Instead, doctors must “exclude” (rule out) other dangerous conditions that look exactly like it [1][10]. This process is why you likely underwent dozens of tests and scans.

The Top Mimics

Doctors must ensure your symptoms aren’t being caused by one of these three categories:

  1. Infections: Serious infections like sepsis or endocarditis (an infection of the heart valves) can cause the same spiking fevers and rashes as AOSD [11][12].
  2. Malignancies (Cancers): Certain blood cancers, particularly lymphoma, are the most important mimics to rule out [9][13]. Both can cause swollen lymph nodes, fever, and night sweats.
  3. Other Autoimmune Diseases: Conditions like Systemic Lupus Erythematosus (SLE) can overlap with AOSD symptoms, requiring careful blood work to distinguish between them [13][14].

Tools for Differentiation

To tell these apart, your medical team likely used specialized tools:

  • Ferritin and Glycosylated Ferritin: While almost all inflammatory diseases raise ferritin (an iron-storage protein), AOSD often causes it to skyrocket to extraordinary levels [15][16]. A specific version called glycosylated ferritin is often low (below 20%) in AOSD, which helps confirm the diagnosis [17][18].
  • PET/CT Scans: These imaging tests look for “hot spots” of inflammation. In AOSD, doctors often see a specific pattern of activity in the neck and armpit lymph nodes, which helps distinguish it from the patterns seen in lymphoma [19][20].
  • Biopsies: If there is any doubt about cancer, a bone marrow biopsy or lymph node biopsy is the “gold standard” to definitively rule out malignancy [19][21].

By systematically ruling out these “mimics,” your doctors reached the diagnosis of AOSD, allowing them to stop testing for what you don’t have and start treating what you do have.

Common questions in this guide

Why is Adult-onset Still's Disease considered a diagnosis of exclusion?
AOSD is called a diagnosis of exclusion because there is no single test that definitively proves you have it. Instead, doctors must run extensive tests to rule out other serious conditions that cause the exact same symptoms, such as infections and cancers.
What is glycosylated ferritin and why is it important in diagnosing AOSD?
Ferritin is an iron-storage protein that often skyrockets during severe inflammation. In AOSD, a specific type called glycosylated ferritin typically drops abnormally low (below 20%), which serves as a key clue to help doctors confirm the diagnosis.
How do doctors rule out lymphoma when diagnosing AOSD?
Because lymphoma and AOSD share symptoms like swollen lymph nodes, fevers, and night sweats, doctors use specialized tools to tell them apart. This often includes PET/CT scans to look for specific inflammation patterns or a biopsy to definitively rule out cancer.
What role does the NLRP3 inflammasome play in AOSD?
The NLRP3 inflammasome is an internal sensor within your innate immune system. In AOSD, this sensor becomes hyperactive and acts like a fire alarm stuck in the 'on' position, unnecessarily flooding your body with inflammatory proteins.
Why do doctors check my IL-18 levels?
Interleukin-18 (IL-18) is an inflammatory protein that is often extremely elevated in patients with AOSD. Doctors monitor IL-18 levels to track your disease activity and evaluate your risk for developing severe complications.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was my glycosylated ferritin level tested, and did it fall below the 20% threshold commonly seen in AOSD?
  2. 2.How were lymphoma and other 'look-alike' cancers ruled out in my case? Did I need a biopsy?
  3. 3.Do the results of my PET/CT scan show the specific lymph node patterns (like cervical or axillary uptake) typical of AOSD?
  4. 4.What do my IL-18 levels tell us about my risk for complications like Macrophage Activation Syndrome (MAS)?
  5. 5.If my symptoms don't improve with current treatment, what other conditions should we reconsider?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    A comprehensive review on adult onset Still's disease.

    Giacomelli R, Ruscitti P, Shoenfeld Y

    Journal of autoimmunity 2018; (93()):24-36 doi:10.1016/j.jaut.2018.07.018.

    PMID: 30077425
  2. 2

    Adult-onset Still's disease: A disease at the crossroad of innate immunity and autoimmunity.

    Rao S, Tsang LS, Zhao M, et al.

    Frontiers in medicine 2022; (9()):881431 doi:10.3389/fmed.2022.881431.

    PMID: 36072947
  3. 3

    Anti-NLRP3 Inflammasome Natural Compounds: An Update.

    Liu B, Yu J

    Biomedicines 2021; (9(2)) doi:10.3390/biomedicines9020136.

    PMID: 33535473
  4. 4

    The NLRP3 inflammasome: contributions to inflammation-related diseases.

    Chen Y, Ye X, Escames G, et al.

    Cellular & molecular biology letters 2023; (28(1)):51 doi:10.1186/s11658-023-00462-9.

    PMID: 37370025
  5. 5

    NLRP3-Mediated Inflammation in Atherosclerosis and Associated Therapeutics.

    Lu N, Cheng W, Liu D, et al.

    Frontiers in cell and developmental biology 2022; (10()):823387 doi:10.3389/fcell.2022.823387.

    PMID: 35493086
  6. 6

    Interleukin-1/6 Blockade for the Treatment of Severe Steroid-Refractory BNT162b2 Vaccine-Induced Adult-Onset Still's Disease.

    Hugues B, Ben Amer H, Bril F, et al.

    European journal of case reports in internal medicine 2022; (9(8)):003469 doi:10.12890/2022_003469.

    PMID: 36093302
  7. 7

    Evaluation of clinical biomarkers for differential diagnosis of intravascular lymphoma and Still's disease.

    Shima T, Yamauchi Y, Ohtsu M, et al.

    Scientific reports 2025; (15(1)):23901 doi:10.1038/s41598-025-09401-4.

    PMID: 40615490
  8. 8

    The role of C-reactive protein and ferritin in the diagnosis of HLH, adult-onset still's disease, and COVID-19 cytokine storm.

    Goubran M, Spaner C, Stukas S, et al.

    Scientific reports 2024; (14(1)):31306 doi:10.1038/s41598-024-82760-6.

    PMID: 39732949
  9. 9

    Still's Disease Onset in Older Adults: Clinical Features, Diagnosis, and Management.

    Tada Y, Maruyama A, Shirahama Y

    Drugs & aging 2024; (41(9)):713-724 doi:10.1007/s40266-024-01137-6.

    PMID: 39097535
  10. 10

    [18F]FDG-PET/CT Demonstration of Young Adult Onset Stills Disease Mimicking Lymphoma.

    Nawwar AA, Searle J, Hodby K, et al.

    BJR case reports 2022; (8(3)):20210195 doi:10.1259/bjrcr.20210195.

    PMID: 36101734
  11. 11

    A case report of Adult-onset Still's disease as a cause of severe mitral regurgitation.

    Shah SH, Shah MA, Khan MS, Alghamdi FA

    European heart journal. Case reports 2020; (4(4)):1-5 doi:10.1093/ehjcr/ytaa127.

    PMID: 32974464
  12. 12

    Adult-onset Still's disease accompanying noninfective endocarditis.

    Oka K, Yuya Y, Yasuda M, Otsuka F

    Journal of general and family medicine 2020; (21(6)):268-269 doi:10.1002/jgf2.339.

    PMID: 33304724
  13. 13

    Adult-onset Still's disease with multiple lymphadenopathy: a case report and literature review.

    Huang Z, Xu H, Min Q, et al.

    Diagnostic pathology 2021; (16(1)):97 doi:10.1186/s13000-021-01159-3.

    PMID: 34706737
  14. 14

    A Case of Adult-Onset Still's Disease with Positive Antinuclear Antibodies.

    Lakshman H, Athwal PSS, Gondi A, et al.

    Cureus 2020; (12(10)):e10761 doi:10.7759/cureus.10761.

    PMID: 33150111
  15. 15

    Febrile Exanthem with Hyperferritinemia.

    Caputo GM, Dyer JM, Ryan EF

    The Journal of clinical and aesthetic dermatology 2015; (8(11)):53-5.

    PMID: 26705442
  16. 16

    Febrile Rash, Shock, and Hyperferritinaemia in A Young Woman: Navigating the Diagnostic Overlap of Hemophagocytic Lymphohistiocytosis, Toxic Shock, and Viral Exanthema.

    Srinivasaiah PH, Surabhi KV

    European journal of case reports in internal medicine 2025; (12(12)):005887 doi:10.12890/2025_005887.

    PMID: 41377779
  17. 17

    Proposal of a new diagnostic algorithm for adult-onset Still's disease.

    Daghor-Abbaci K, Ait Hamadouche N, Makhloufi CD, et al.

    Clinical rheumatology 2023; (42(4)):1125-1135 doi:10.1007/s10067-023-06509-8.

    PMID: 36694091
  18. 18

    Evaluation of Glycosylated Ferritin in Adult-Onset Still's Disease and Differential Diagnoses.

    Guerber A, Garneret E, El Jammal T, et al.

    Journal of clinical medicine 2022; (11(17)) doi:10.3390/jcm11175012.

    PMID: 36078942
  19. 19

    Utilization of PET in diagnosing adult-onset Still's disease: a systematic review.

    Cajamarca-Baron J, Castañeda-Gonzalez JP, Acelas-Gonzalez GE, et al.

    Nuclear medicine communications 2025; (46(11)):1020-1028 doi:10.1097/MNM.0000000000002039.

    PMID: 40838726
  20. 20

    The role of PET/CT scan in addressing autoinflammatory diseases; A case report of a young man presenting with fever, splenomegaly and exanthem.

    Geladari EV, Pianou NK, Angelis NA, et al.

    Hellenic journal of nuclear medicine 2024; (27(3)):243-246 doi:10.1967/s002449912759.

    PMID: 39644276
  21. 21

    An Extensive Analysis and Comparison of Bone Marrow Aspiration and Bone Marrow Trephine Biopsy at a Tertiary Care Hospital in Jharkhand for Various Hematological and Non-hematological Illnesses.

    Jawed MA, Paswan MK, Mahto SK, et al.

    Cureus 2024; (16(6)):e62661 doi:10.7759/cureus.62661.

    PMID: 39036242

This page provides educational information about AOSD biology and diagnostic testing. It is not intended to replace professional medical advice. Always consult your rheumatologist or healthcare provider to discuss your specific diagnosis and test results.

Get notified when new evidence is published on Adult-onset Still disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.